Status:
RECRUITING
Borrelia B-cell Diagnostics
Lead Sponsor:
University Children's Hospital, Zurich
Collaborating Sponsors:
University of Zurich
Conditions:
Lyme Disease
Borrelia Infections
Eligibility:
All Genders
1-17 years
Brief Summary
The investigators propose a single center, prospective observational study in children with Lyme disease (LD), the Borrelia B-cell diagnostics (BRILLIANT) study, to assess the immune response against ...
Detailed Description
Background: Lyme disease (LD) is the most common tick born disease in Europe. It is caused by an infection with several genospecies of the spirochaetal bacteria Borrelia burgdorferi (Bb). Although c...
Eligibility Criteria
Inclusion
- Patients presenting at the ED with differential diagnosis of LD according to the treating physician
Exclusion
- Patients will be excluded in cases of primary or secondary immunodeficiency
Key Trial Info
Start Date :
April 2 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2028
Estimated Enrollment :
502 Patients enrolled
Trial Details
Trial ID
NCT06045416
Start Date
April 2 2024
End Date
November 1 2028
Last Update
January 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chidren's Hospital Zurich
Zurich, Switzerland